Oncobit

Cambridge Cancer Genomics

This company develops precision oncology software for clinicians to monitor treatment response and detect cancer relapse using genomic data and blood samples.

Predicta Biosciences

This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.

Oncoliq

This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.

Oxford Cancer Biomarkers

This company develops and commercialises precision diagnostic tests and digital pathology tools to help clinicians personalise cancer treatment and assess patient toxicity risks.

Astron Health

This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.

Elphogene

This biotechnology company develops a molecular liquid biopsy test to monitor cancer progression and treatment efficacy for oncology patients and healthcare professionals.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.